サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
市場調査レポート
商品コード
1101487

粒子線治療の世界市場（治療法別：陽子線治療、重粒子線治療、サービス別：サイクロトロン、シンクロトロン、シンクロサイクロトロン）：業界分析、市場規模、シェア、成長、動向、予測（2022年～2031年）

Particle Therapy Market (Therapy: Proton Therapy and Heavy Ion Therapy; Service: Cyclotrons, Synchrotrons, and Synchrocyclotrons) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2022-2031
出版日: | 発行: Transparency Market Research | ページ情報: 英文 230 Pages | 納期: 2～10営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=155.86円
粒子線治療の世界市場（治療法別：陽子線治療、重粒子線治療、サービス別：サイクロトロン、シンクロトロン、シンクロサイクロトロン）：業界分析、市場規模、シェア、成長、動向、予測（2022年～2031年）
出版日: 2022年05月05日
発行: Transparency Market Research
ページ情報: 英文 230 Pages
納期: 2～10営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

当レポートでは、世界の粒子線治療市場について調査分析し、市場概要、市場分析、競合情勢など、体系的な情報を提供しています。

目次

第1章 序文

第2章 仮定と調査手法

第3章 エグゼクティブサマリー：世界の粒子線治療市場

第4章 市場概要

  • イントロダクション
  • 概要
  • 市場力学
    • 促進要因
    • 抑制要因
    • 市場機会
  • 世界の粒子線治療市場の分析と予測（2017年～2031年）
    • 市場収益予測（100万米ドル）

第5章 重要な洞察

  • 技術の進歩
  • 償還シナリオ
  • 臨床運用中の粒子線治療施設（2021年）
  • 平均価格（2021年）：地域別
  • COVID-19パンデミックによる業界への影響（バリューチェーンおよび短期/中期/長期の影響）

第6章 世界の粒子線治療市場の分析と予測：治療法別

  • イントロダクションと定義
  • 主な調査結果/開発
  • 市場金額予測（2017年～2031年）：治療法別
    • 陽子線治療
    • 重イオン療法（炭素療法、He、パイ中間子）
  • 市場魅力分析：治療法別

第7章 世界の粒子線治療市場の分析と予測：アプリケーション別

  • イントロダクションと定義
  • 主な調査結果/開発
  • 市場金額予測（2017年～2031年）：アプリケーション別
    • 小児がん
    • 肺がん
    • 膀胱がん
    • 脳および脊髄腫瘍（BSCT）
    • 乳がん
    • 胃腸（GI）がん
    • 肝細胞がん（HCC）
    • 頭頸部がん（HNC）
    • その他
  • 市場魅力分析：アプリケーション別

第8章 世界の粒子線治療市場の分析と予測：サービス別

  • イントロダクションと定義
  • 主な調査結果/開発
  • 市場金額予測（2017年～2031年）：サービス別
    • サイクロトロン
    • シンクロトロン
    • シンクロサイクロトロン
  • 市場魅力分析：サービス別

第9章 世界の粒子線治療市場の分析と予測：エンドユーザー別

  • イントロダクションと定義
  • 主な調査結果/開発
  • 市場金額予測（2017～2031年）：エンドユーザー別
    • 病院
    • 学術・研究センター
  • 市場魅力分析：エンドユーザー別

第10章 世界の粒子線治療市場の分析と予測：地域別

  • 主な調査結果
  • 市場金額予測：地域別
    • 北米
    • 欧州
    • アジア太平洋
    • その他の地域
  • 市場魅力分析：地域別

第11章 北米の粒子線治療市場の分析と予測

第12章 欧州の粒子線治療市場の分析と予測

第13章 アジア太平洋地域の粒子線治療市場の分析と予測

第14章 その他の粒子線治療市場の分析と予測

第15章 競合情勢

  • 市場参入企業－競合マトリックス（企業の層と規模別）
  • 市場シェア分析（2020年）：企業別
  • 企業プロファイル
    • Advanced Oncotherapy plc
    • Danfysik A/S
    • Hitachi, Ltd.
    • IBA Worldwide
    • Mevion Medical Systems, Inc.
    • Optivus Proton Therapy, Inc.
    • Protom International, Inc.
    • Provision Healthcare
    • Sumitomo Heavy Industries, Ltd.
    • Varian Medical Systems, Inc.
図表

List of Tables

  • Table 01: Global Particle Therapy Market Value (US$ Mn) Forecast, by Therapy 2017-2031
  • Table 02: Global Particle Therapy Market Value (US$ Mn) Forecast, by Application, 2017-2031
  • Table 03: Global Particle Therapy Market Value (US$ Mn) Forecast, by Service, 2017-2031
  • Table 04: Global Particle Therapy Market Value (US$ Mn) Forecast, by End-user, 2017-2031
  • Table 05: Global Particle Therapy Market Value (US$ Mn) Forecast, by Region, 2017-2031
  • Table 06: North America Particle Therapy Market Value (US$ Mn) Forecast, by Country, 2017-2031
  • Table 07: North America Particle Therapy Market Value (US$ Mn) Forecast, by Therapy, 2017-2031
  • Table 08: North America Particle Therapy Market (US$ Mn) Forecast, by Application, 2017-2031
  • Table 09: North America Particle Therapy Market Value (US$ Mn) Forecast, by Service, 2017-2031
  • Table 10: North America Particle Therapy Market Value (US$ Mn) Forecast, by End-user, 2017-2031
  • Table 11: Europe Particle Therapy Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
  • Table 12: Europe Particle Therapy Market Value (US$ Mn) Forecast, by Therapy, 2017-2031
  • Table 13: Europe Particle Therapy Market (US$ Mn) Forecast, by Application, 2017-2031
  • Table 14: Europe Particle Therapy Market Value (US$ Mn) Forecast, by Service, 2017-2031
  • Table 15: Europe Particle Therapy Market Value (US$ Mn) Forecast, by End-user, 2017-2031
  • Table 16: Asia Pacific Particle Therapy Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
  • Table 17: Asia Pacific Particle Therapy Market Value (US$ Mn) Forecast, by Therapy, 2017-2031
  • Table 18: Asia Pacific Particle Therapy Market (US$ Mn) Forecast, by Application, 2017-2031
  • Table 19: Asia Pacific Particle Therapy Market Value (US$ Mn) Forecast, by Service, 2017-2031
  • Table 20: Asia Pacific Particle Therapy Market Value (US$ Mn) Forecast, by End-user, 2017-2031
  • Table 21: Rest of the World Particle Therapy Market Value (US$ Mn) Forecast, by Therapy, 2017-2031
  • Table 22: Rest of the World Particle Therapy Market (US$ Mn) Forecast, by Application, 2017-2031
  • Table 23: Rest of the World Particle Therapy Market Value (US$ Mn) Forecast, by Service, 2017-2031
  • Table 24: Rest of the World Particle Therapy Market Value (US$ Mn) Forecast, by End-user, 2017-2031

List of Figures

  • Figure 01: Global Particle Therapy market Value (US$ Mn) Forecast, 2017-2031
  • Figure 02: Global Particle Therapy Market Value Share Analysis, by Therapy, 2021 and 2031
  • Figure 03: Global Particle Therapy Market Attractiveness Analysis, by Therapy, 2022-2031
  • Figure 04: Global Particle Therapy Market Value (US$ Mn) Forecast, by Proton Therapy, 2017-2031
  • Figure 05: Global Particle Therapy Market Value (US$ Mn) Forecast, by Heavy Ion Therapy, 2017-2031
  • Figure 06: Global Particle Therapy Market Value Share Analysis, by Application, 2021 and 2031
  • Figure 07: Global Particle Therapy Market Attractiveness Analysis, by Application, 2022-2031
  • Figure 08: Global Particle Therapy Market Value (US$ Mn) Forecast, by Pediatric Cancer, 2017-2031
  • Figure 09: Global Particle Therapy Market Value (US$ Mn) Forecast, by Lung Cancer, 2017-2031
  • Figure 10: Global Particle Therapy Market Value (US$ Mn) Forecast, by Bladder Cancer, 2017-2031
  • Figure 11: Global Particle Therapy Market Value (US$ Mn) Forecast, by Brain &Spinal Cord Tumors, 2017-2031
  • Figure 12: Global Particle Therapy Market Value (US$ Mn) Forecast, by Breast Cancer, 2017-2031
  • Figure 13: Global Particle Therapy Market Value (US$ Mn) Forecast, by Gastrointestinal (GI) Cancers, 2017-2031
  • Figure 14: Global Particle Therapy Market Value (US$ Mn) Forecast, by Hepatocellular Carcinoma (HCC), 2017-2031
  • Figure 15: Global Particle Therapy Market Value (US$ Mn) Forecast, by Head & Neck Cancers (HNC), 2017-2031
  • Figure 16: Global Particle Therapy Market Value (US$ Mn) Forecast, by Other Cancers, 2017-2031
  • Figure 17: Global Particle Therapy Market, by Service, 2021 and 2031
  • Figure 18: Global Particle Therapy Market Attractiveness Analysis, by Service, 2022-2031
  • Figure 19: Global Particle Therapy Market Value (US$ Mn) Forecast, by Cyclotrons, 2017-2031
  • Figure 20: Global Particle Therapy Market Value (US$ Mn) Forecast, by Synchrotrons, 2017-2031
  • Figure 21: Global Particle Therapy Market Value (US$ Mn) Forecast, by Synchrocyclotrons, 2017-2031
  • Figure 22: Global Particle Therapy Market Value Share Analysis, by End-user, 2021 and 2031
  • Figure 23: Global Particle Therapy Market Attractiveness Analysis, by End-user, 2022-2031
  • Figure 24: Global Particle Therapy Market (US$ Mn), by Hospitals, 2017-2031
  • Figure 25: Global Particle Therapy Market (US$ Mn), by Academic & Research Institutes, 2017-2031
  • Figure 26: Global Particle Therapy Market Value Share Analysis, by Region, 2021 and 2031
  • Figure 27: Global Particle Therapy Market Attractiveness Analysis, by Region, 2022-2031
  • Figure 28: North America Particle Therapy Market Value (US$ Mn) Forecast, 2017-2031
  • Figure 29: North America Particle Therapy Market Value Share Analysis, by Country, 2021 and 2031
  • Figure 30: North America Particle Therapy Market Attractiveness Analysis, by Country, 2022-2031
  • Figure 31: North America Particle Therapy Market Value Share Analysis, by Therapy, 2021 and 2031
  • Figure 32: North America Particle Therapy Market Attractiveness Analysis, by Therapy, 2022-2031
  • Figure 33: North America Particle Therapy Market Value Share Analysis, by Application, 2021 and 2031
  • Figure 34: North America Particle Therapy Market Attractiveness Analysis, by Application, 2022-2031
  • Figure 35: North America Particle Therapy Market Value Share Analysis, by Service, 2021 and 2031
  • Figure 36: North America Particle Therapy Market Attractiveness Analysis, by Service, 2022-2031
  • Figure 37: North America Particle Therapy Market Value Share Analysis, by End-user, 2021 and 2031
  • Figure 38: North America Particle Therapy Market Attractiveness Analysis, by End-user, 2022-2031
  • Figure 39: Europe Particle Therapy Market Value (US$ Mn) Forecast, 2017-2031
  • Figure 40: Europe Particle Therapy Market Value Share Analysis, by Country/Sub-region, 2021 and 2031
  • Figure 41: Europe Particle Therapy Market Attractiveness Analysis, by Country/Sub-region, 2022-2031
  • Figure 42: Europe Particle Therapy Market Value Share Analysis, by Therapy, 2021 and 2031
  • Figure 43: Europe Particle Therapy Market Attractiveness Analysis, by Therapy, 2022-2031
  • Figure 44: Europe Particle Therapy Market Value Share Analysis, by Application, 2021 and 2031
  • Figure 45: Europe Particle Therapy Market Attractiveness Analysis, by Application, 2022-2031
  • Figure 46: Europe Particle Therapy Market Value Share Analysis, by Service, 2021 and 2031
  • Figure 47: Europe Particle Therapy Market Attractiveness Analysis, by Service, 2022-2031
  • Figure 48: Europe Particle Therapy Market Value Share Analysis, by End-user, 2021 and 2031
  • Figure 49: Europe Particle Therapy Market Attractiveness Analysis, by End-user, 2022-2031
  • Figure 50: Asia Pacific Particle Therapy Market Value (US$ Mn) Forecast, 2017-2031
  • Figure 51: Asia Pacific Particle Therapy Market Value Share Analysis, by Country/Sub-region, 2021 and 2031
  • Figure 52: Asia Pacific Particle Therapy Market Attractiveness Analysis, by Country/Sub-region, 2022-2031
  • Figure 53: Asia Pacific Particle Therapy Market Value Share Analysis, by Therapy, 2021 and 2031
  • Figure 54: Asia Pacific Particle Therapy Market Attractiveness Analysis, by Therapy, 2022-2031
  • Figure 55: Asia Pacific Particle Therapy Market Value Share Analysis, by Application, 2021 and 2031
  • Figure 56: Asia Pacific Particle Therapy Market Attractiveness Analysis, by Application, 2022-2031
  • Figure 57: Asia Pacific Particle Therapy Market Value Share Analysis, by Service, 2021 and 2031
  • Figure 58: Asia Pacific Particle Therapy Market Attractiveness Analysis, by Service, 2022-2031
  • Figure 59: Asia Pacific Particle Therapy Market Value Share Analysis, by End-user, 2021 and 2031
  • Figure 60: Asia Pacific Particle Therapy Market Attractiveness Analysis, by End-user, 2022-2031
  • Figure 61: Rest of the World Particle Therapy Market Value (US$ Mn) Forecast, 2017-2031
  • Figure 62: Rest of the World Particle Therapy Market Value Share Analysis, by Therapy, 2021 and 2031
  • Figure 63: Rest of the World Particle Therapy Market Attractiveness Analysis, by Therapy, 2022-2031
  • Figure 64: Rest of the World Particle Therapy Market Value Share Analysis, by Application, 2021 and 2031
  • Figure 65: Rest of the World Particle Therapy Market Attractiveness Analysis, by Application, 2022-2031
  • Figure 66: Rest of the World Particle Therapy Market Value Share Analysis, by Service, 2021 and 2031
  • Figure 67: Rest of the World Particle Therapy Market Attractiveness Analysis, by Service, 2022-2031
  • Figure 68: Rest of the World Particle Therapy Market Value Share Analysis, by End-user, 2021 and 2031
  • Figure 69: Rest of the World Particle Therapy Market Attractiveness Analysis, by End-user, 2022-2031
目次
Product Code: TMRGL56133

The report provides revenue of the global particle therapy market for the period 2017-2031, considering 2021 as the base year and 2031 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global particle therapy market from 2022 to 2031.

The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players' product literature, annual reports, press releases, and relevant documents to understand the particle therapy market.

The report delves into the competitive landscape of the global particle therapy market. Key players operating in the global particle therapy market have been identified and each one of these has been profiled, in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are attributes of players in the global particle therapy market profiled in this report.

Table of Contents

1. Preface

  • 1.1. Market Definition and Scope
  • 1.2. Market Segmentation
  • 1.3. Key Research Objectives
  • 1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary: Global Particle Therapy Market

4. Market Overview

  • 4.1. Introduction
  • 4.2. Overview
  • 4.3. Market Dynamics
    • 4.3.1. Drivers
    • 4.3.2. Restraints
    • 4.3.3. Opportunities
  • 4.4. Global Particle Therapy Market Analysis and Forecast, 2017-2031
    • 4.4.1. Market Revenue Projections (US$ Mn)

5. Key Insights

  • 5.1. Technological Advancements
  • 5.2. Reimbursement Scenario
  • 5.3. Particle Therapy Facilities In Clinical Operation, 2021
  • 5.4. Average Prices, by Region, 2021
  • 5.5. COVID-19 Pandemics Impact on Industry (value chain and short / mid / long term impact)

6. Global Particle Therapy Market Analysis and Forecast, By Therapy

  • 6.1. Introduction & Definition
  • 6.2. Key Findings / Developments
  • 6.3. Market Value Forecast, by Therapy, 2017-2031
    • 6.3.1. Proton Therapy
    • 6.3.2. Heavy Ion Therapy (carbon therapy, He, pion)
  • 6.4. Market Attractiveness Analysis, By Therapy

7. Global Particle Therapy Market Analysis and Forecast, By Application

  • 7.1. Introduction & Definition
  • 7.2. Key Findings / Developments
  • 7.3. Market Value Forecast, by Application, 2017-2031
    • 7.3.1. Pediatric Cancer
    • 7.3.2. Lung Cancer
    • 7.3.3. Bladder Cancer
    • 7.3.4. Brain & Spinal Cord Tumors (BSCT)
    • 7.3.5. Breast Cancer
    • 7.3.6. Gastrointestinal (GI) Cancers
    • 7.3.7. Hepatocellular Carcinoma (HCC)
    • 7.3.8. Head & Neck Cancers (HNC)
    • 7.3.9. Others
  • 7.4. Market Attractiveness Analysis, By Application

8. Global Particle Therapy Market Analysis and Forecast, By Service

  • 8.1. Introduction & Definition
  • 8.2. Key Findings / Developments
  • 8.3. Market Value Forecast, by Service, 2017-2031
    • 8.3.1. Cyclotrons
    • 8.3.2. Synchrotrons
    • 8.3.3. Synchrocyclotrons
  • 8.4. Market Attractiveness Analysis, By Service

9. Global Particle Therapy Market Analysis and Forecast, By End-user

  • 9.1. Introduction & Definition
  • 9.2. Key Findings / Developments
  • 9.3. Market Value Forecast, by End-user, 2017-2031
    • 9.3.1. Hospitals
    • 9.3.2. Academic & Research Centers
  • 9.4. Market Attractiveness Analysis, By End-user

10. Global Particle Therapy Market Analysis and Forecast, By Region

  • 10.1. Key Findings
  • 10.2. Market Value Forecast, by Region
    • 10.2.1. North America
    • 10.2.2. Europe
    • 10.2.3. Asia Pacific
    • 10.2.4. Rest of the World
  • 10.3. Market Attractiveness Analysis, By Region

11. North America Particle Therapy Market Analysis and Forecast

  • 11.1. Introduction
    • 11.1.1. Key Findings
  • 11.2. Market Value Forecast, by Therapy, 2017-2031
    • 11.2.1. Proton Therapy
    • 11.2.2. Heavy Ion Therapy (carbon therapy, He, pion)
  • 11.3. Market Value Forecast, by Application, 2017-2031
    • 11.3.1. Pediatric Cancer
    • 11.3.2. Lung Cancer
    • 11.3.3. Bladder Cancer
    • 11.3.4. Brain & Spinal Cord Tumors (BSCT)
    • 11.3.5. Breast Cancer
    • 11.3.6. Gastrointestinal (GI) Cancers
    • 11.3.7. Hepatocellular Carcinoma (HCC)
    • 11.3.8. Head & Neck Cancers (HNC)
    • 11.3.9. Others
  • 11.4. Market Value Forecast, by Service, 2017-2031
    • 11.4.1. Cyclotrons
    • 11.4.2. Synchrotrons
    • 11.4.3. Synchrocyclotrons
  • 11.5. Market Value Forecast, by End-user, 2017-2031
    • 11.5.1. Hospitals
    • 11.5.2. Academic & Research Centers
  • 11.6. Market Value Forecast, by Country, 2017-2031
    • 11.6.1. U.S.
    • 11.6.2. Canada
  • 11.7. Market Attractiveness Analysis
    • 11.7.1. By Therapy
    • 11.7.2. By Application
    • 11.7.3. By Service
    • 11.7.4. By End-user
    • 11.7.5. By Country

12. Europe Particle Therapy Market Analysis and Forecast

  • 12.1. Introduction
    • 12.1.1. Key Findings
  • 12.2. Market Value Forecast, by Therapy, 2017-2031
    • 12.2.1. Proton Therapy
    • 12.2.2. Heavy Ion Therapy (carbon therapy, He, pion)
  • 12.3. Market Value Forecast, by Application, 2017-2031
    • 12.3.1. Pediatric Cancer
    • 12.3.2. Lung Cancer
    • 12.3.3. Bladder Cancer
    • 12.3.4. Brain & Spinal Cord Tumors (BSCT)
    • 12.3.5. Breast Cancer
    • 12.3.6. Gastrointestinal (GI) Cancers
    • 12.3.7. Hepatocellular Carcinoma (HCC)
    • 12.3.8. Head & Neck Cancers (HNC)
    • 12.3.9. Others
  • 12.4. Market Value Forecast, by Service, 2017-2031
    • 12.4.1. Cyclotrons
    • 12.4.2. Synchrotrons
    • 12.4.3. Synchrocyclotrons
  • 12.5. Market Value Forecast, by End-user, 2017-2031
    • 12.5.1. Hospitals
    • 12.5.2. Academic & Research Centers
  • 12.6. Market Value Forecast, by Country/Sub-region, 2017-2031
    • 12.6.1. Germany
    • 12.6.2. U.K.
    • 12.6.3. France
    • 12.6.4. Spain
    • 12.6.5. Italy
    • 12.6.6. Rest of Europe
  • 12.7. Market Attractiveness Analysis
    • 12.7.1. By Therapy
    • 12.7.2. By Application
    • 12.7.3. By Service
    • 12.7.4. By End-user
    • 12.7.5. By Country/Sub-region

13. Asia Pacific Particle Therapy Market Analysis and Forecast

  • 13.1. Introduction
    • 13.1.1. Key Findings
  • 13.2. Market Value Forecast, by Therapy, 2017-2031
    • 13.2.1. Proton Therapy
    • 13.2.2. Heavy Ion Therapy (carbon therapy, He, pion)
  • 13.3. Market Value Forecast, by Application, 2017-2031
    • 13.3.1. Pediatric Cancer
    • 13.3.2. Lung Cancer
    • 13.3.3. Bladder Cancer
    • 13.3.4. Brain & Spinal Cord Tumors (BSCT)
    • 13.3.5. Breast Cancer
    • 13.3.6. Gastrointestinal (GI) Cancers
    • 13.3.7. Hepatocellular Carcinoma (HCC)
    • 13.3.8. Head & Neck Cancers (HNC)
    • 13.3.9. Others
  • 13.4. Market Value Forecast, by Service, 2017-2031
    • 13.4.1. Cyclotrons
    • 13.4.2. Synchrotrons
    • 13.4.3. Synchrocyclotrons
  • 13.5. Market Value Forecast, by End-user, 2017-2031
    • 13.5.1. Hospitals
    • 13.5.2. Academic & Research Centers
  • 13.6. Market Value Forecast, by Country/Sub-region, 2017-2031
    • 13.6.1. China
    • 13.6.2. Japan
    • 13.6.3. India
    • 13.6.4. Australia & New Zealand
    • 13.6.5. Rest of Asia Pacific
  • 13.7. Market Attractiveness Analysis
    • 13.7.1. By Therapy
    • 13.7.2. By Application
    • 13.7.3. By Service
    • 13.7.4. By End-user
    • 13.7.5. By Country/Sub-region

14. Rest of the World Particle Therapy Market Analysis and Forecast

  • 14.1. Introduction
    • 14.1.1. Key Findings
  • 14.2. Market Value Forecast, by Therapy, 2017-2031
    • 14.2.1. Proton Therapy
    • 14.2.2. Heavy Ion Therapy (carbon therapy, He, pion)
  • 14.3. Market Value Forecast, by Application, 2017-2031
    • 14.3.1. Pediatric Cancer
    • 14.3.2. Lung Cancer
    • 14.3.3. Bladder Cancer
    • 14.3.4. Brain & Spinal Cord Tumors (BSCT)
    • 14.3.5. Breast Cancer
    • 14.3.6. Gastrointestinal (GI) Cancers
    • 14.3.7. Hepatocellular Carcinoma (HCC)
    • 14.3.8. Head & Neck Cancers (HNC)
    • 14.3.9. Others
  • 14.4. Market Value Forecast, by Service, 2017-2031
    • 14.4.1. Cyclotrons
    • 14.4.2. Synchrotrons
    • 14.4.3. Synchrocyclotrons
  • 14.5. Market Value Forecast, by End-user, 2017-2031
    • 14.5.1. Hospitals
    • 14.5.2. Academic & Research Centers
  • 14.6. Market Attractiveness Analysis
    • 14.6.1. By Therapy
    • 14.6.2. By Application
    • 14.6.3. By Service
    • 14.6.4. By End-user

15. Competition Landscape

  • 15.1. Market Player - Competition Matrix (by tier and size of companies)
  • 15.2. Market Share Analysis, by Company, 2020
  • 15.3. Company Profiles
    • 15.3.1. Advanced Oncotherapy plc
      • 15.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 15.3.1.2. Product Portfolio
      • 15.3.1.3. SWOT Analysis
      • 15.3.1.4. Strategic Overview
    • 15.3.2. Danfysik A/S
      • 15.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 15.3.2.2. Product Portfolio
      • 15.3.2.3. SWOT Analysis
      • 15.3.2.4. Strategic Overview
    • 15.3.3. Hitachi, Ltd.
      • 15.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 15.3.3.2. Product Portfolio
      • 15.3.3.3. SWOT Analysis
      • 15.3.3.4. Strategic Overview
    • 15.3.4. IBA Worldwide
      • 15.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 15.3.4.2. Product Portfolio
      • 15.3.4.3. SWOT Analysis
      • 15.3.4.4. Strategic Overview
    • 15.3.5. Mevion Medical Systems, Inc.
      • 15.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 15.3.5.2. Product Portfolio
      • 15.3.5.3. SWOT Analysis
      • 15.3.5.4. Strategic Overview
    • 15.3.6. Optivus Proton Therapy, Inc.
      • 15.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 15.3.6.2. Product Portfolio
      • 15.3.6.3. SWOT Analysis
      • 15.3.6.4. Strategic Overview
    • 15.3.7. Protom International, Inc.
      • 15.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 15.3.7.2. Product Portfolio
      • 15.3.7.3. SWOT Analysis
      • 15.3.7.4. Strategic Overview
    • 15.3.8. Provision Healthcare
      • 15.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 15.3.8.2. Product Portfolio
      • 15.3.8.3. SWOT Analysis
      • 15.3.8.4. Strategic Overview
    • 15.3.9. Sumitomo Heavy Industries, Ltd.
      • 15.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 15.3.9.2. Product Portfolio
      • 15.3.9.3. SWOT Analysis
      • 15.3.9.4. Strategic Overview
    • 15.3.10. Varian Medical Systems, Inc.
      • 15.3.10.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 15.3.10.2. Product Portfolio
      • 15.3.10.3. SWOT Analysis
      • 15.3.10.4. Strategic Overview